MWISEMAN TM LTD

Executive Summary

MWISEMAN TM LTD is in the early start-up phase with limited assets and a negative working capital position, indicating liquidity challenges typical for a young company. While the financial structure is fragile, there is potential for stabilization through improved cash flow management and capital support. Immediate focus on liquidity and cost control is critical to ensure ongoing operational health and growth prospects.

MWISEMAN TM LTD - Analysis Report

Company Number: 14774477

Analysis Date: 2025-07-29 20:31 UTC

Financial Health Assessment for MWISEMAN TM LTD (as of 31 March 2024)

---

1. Financial Health Score: D

Explanation:
The company exhibits early-stage operational characteristics with a very limited asset base and working capital deficit, indicating initial financial strain typical of a start-up phase. While not critical, the negative net current assets ("working capital") and minimal equity suggest vulnerability and a need for strengthening liquidity and capital structure. This grade reflects caution but acknowledges the company’s very recent incorporation and early trading.

---

2. Key Vital Signs

Metric	Value (£)	Interpretation
Fixed Assets (Intangible)	5,400	Investment in goodwill, likely acquisition-related or start-up cost.
Current Assets	10,651	Entirely cash, indicating no debtors or stock yet.
Current Liabilities	15,855	Short-term obligations exceed cash, causing liquidity pressure.
Net Current Assets (Working Capital)	-5,204	Negative working capital; company cannot cover short-term debts with current assets.
Net Assets (Equity)	196	Very low equity base, almost at break-even level.
Share Capital	1	Nominal share capital, typical for new private company.
Profit & Loss Reserve	195	Minimal retained earnings, possibly early profits or initial funding.

---

3. Diagnosis

• Liquidity Symptoms: The company shows "symptoms of distress" in liquidity with a negative working capital of £5,204. This means it currently does not have enough liquid assets (cash or equivalents) to meet its short-term liabilities. This can cause operational strain, especially if creditors demand payment promptly.

• Capital Structure: The net assets of just £196 and a share capital of £1 indicate the company is still in a nascent phase, with minimal financial buffer. The small equity base means reliance on external funding or improved operational cash flow is critical.

• Asset Composition: The fixed asset is intangible goodwill valued at £5,400, amortised over 10 years. This suggests some initial investment or acquisition costs but no tangible assets like equipment or property yet.

• Operating Scale: With an average of 2 employees and being recently incorporated (April 2023), the company is in the start-up or early development phase. Its SIC code (42110) places it in road and motorway construction, which typically requires upfront investment and working capital.

• Financial Reporting: The accounts are unaudited but prepared in compliance with UK small companies regime, which is standard for a company of this size and age.

---

4. Prognosis

If the company can improve its working capital position through increased cash inflows (e.g., from customers or additional capital injection) and manage liabilities carefully, it has a reasonable outlook given its start-up status. However, ongoing negative working capital poses a "risk of financial stress" if not addressed soon. Continued close cash flow monitoring and operational scaling are essential.

---

5. Recommendations

• Improve Liquidity: Prioritize converting any receivables to cash quickly and negotiate longer payment terms with creditors to ease short-term cash outflows.

• Capital Injection: Consider additional equity investment or short-term financing to bolster working capital and provide a financial cushion.

• Cost Control: Maintain strict control over overheads and operating costs during this early phase to avoid cash burn.

• Cash Flow Forecasting: Implement regular cash flow forecasting to anticipate liquidity needs and avoid surprises.

• Growth Strategy: Focus on securing contracts/payments that improve cash position and build tangible assets over time.

• Monitoring: Regularly review financial metrics monthly rather than annually to detect early signs of distress.

---

Medical Analogy Summary

MWISEMAN TM LTD presents with the "symptoms of early-stage financial strain," akin to a patient who has just begun treatment but whose vital signs (cash flow and liquidity) need immediate attention to avoid deterioration. The company’s financial "immune system" is currently fragile, with limited equity reserves and a negative working capital deficit serving as warning signs. With prompt "intervention" through capital support and cash management, the company can stabilize and grow stronger.

---